Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176181 | SCV000227796 | benign | not specified | 2015-04-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000176181 | SCV000512897 | benign | not specified | 2016-03-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001083137 | SCV000559767 | benign | Charcot-Marie-Tooth disease axonal type 2O | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711535 | SCV000841913 | benign | not provided | 2018-03-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314616 | SCV000847485 | benign | Inborn genetic diseases | 2016-03-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000711535 | SCV004130454 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | DYNC1H1: BP4, BP7, BS1 |
Breakthrough Genomics, |
RCV000711535 | SCV005294085 | benign | not provided | criteria provided, single submitter | not provided | ||
ARUP Laboratories, |
RCV000711535 | SCV005877293 | benign | not provided | 2024-10-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000176181 | SCV001921698 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000711535 | SCV001968829 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004745254 | SCV005363201 | benign | DYNC1H1-related disorder | 2024-07-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |